Table II.

Implicated drugs, predictive scores, and latency

Case patient	Drugs implicated	Indication	SCORTEN score∗	Alden score	Naranjo score†	Latency‡ (d)	Receiving at time of rash onset§
1	Benzylpenicillin	Bacteremia	N/A	N/A	4	18	Yes
	Ceftriaxone					33
	Vancomycin					5
2	Meloxicam	Joint pain	N/A	N/A	9	0	Yes
3	Trimethoprim/sulfamethoxazole	PJP prophylaxis	2	5	4	38	Yes
	Pantoprazole	Gastric ulcer prophylaxis		4		38
	Atorvastatin	Nephrotic syndrome		4		38
4	Allopurinol	Gout	4	6	4	19	Yes
	Ibuprofen			5

N/A, Not applicable; PJP, Pneumocystis jiroveci pneumonia.

^∗SCORTEN score to predict mortality in patients with SJS/TEN.¹²

^†Naranjo adverse reaction score for determining the likelihood of an adverse drug reaction actually being due to the implicated drug.¹¹

^‡Latency defined as the time between drug commencement and rash onset (days).

^§Receiving implicated drugs at the onset of rash.